Tacrolimus Biotin Conjugate Solution

• Description:

  Tacrolimus Biotin Conjugate Solution_x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_ _x000D_

  Catalog number:	C2010006
  Lot number:	Batch Dependent
  Expiration date:	Batch Dependent
  Purity:	> 95% by HPLC
  Concentration:	10 mg/mL (in DMSO)
  Package Size:	1 mg  and 5 mg
  Appearance:	Yellow Solution
  Storage:	-20°. Avoid repeated freeze-thaw.
  Other names:	Biotin-Tacrolimus, Biotin conjugated to Tacrolimus, FK506-Biotin, Biotin-FK506, Biotinylated Tacrolimus, Biotinylated FK506.
  Keywords:	Biotin conjugate, Tacrolimus 32, Tacrolimus, FK-506, Fujimycin, Prograf, Advagraf, Protopic.

  _x000D_  _x000D_ _x000D_ Complete Tacrolimus Product Line_x000D_ _x000D_ Download Brochure_x000D_ _x000D_ _x000D_ _x000D_ References_x000D_

  _x000D_
  • Brunet, M., Plana, J. C., and Rimola, A. (2001). Tacrolimus. Madrid: Drug Farma.
  _x000D_
  • Goto, T., and Nakagawa, H. (2004). Development of Tacrolimus Ointment. Tacrolimus Ointment, 81€“98.
  _x000D_
  • Raptis, D., and Pramateftakis, M.-G. (2013). Tacrolimus: Effectiveness, safety and drug interactions. New York: Nova Biomedical.
  _x000D_
  • Plosker, G. L., and Foster, R. H. (2001). Tacrolimus a further update of its pharmacology and therapeutic use in the management of organ transplantation. Auckland: ADIS International.
  _x000D_
  • Kaplan, B., Burckart, G. J., and Lakkis, F. G. (2012). Immunotherapy in transplantation: principles and practice. Chichester, West Sussex, UK: Wiley Blackwell.
  _x000D_
  • Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, Shimojo N, Tanaka A, Nakahara T, Nagao M, Hide M, Fujita Y, Fujisawa T, Futamura M, Masuda K, Murota H, Yamamoto-Hanada K; Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis 2018, Japanasese Society of Allergology, Japanese Dermatology Association. Japanese guidelines for atopic dermatitis 2020. Allergol Int. 2020 Apr 4. pii: S1323-8930(20)30018-6.
  _x000D_
  • Lv X, Qi J, Zhou M, Shi B, Cai C, Tang Y, Pan T, Han Y. Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis. Crit Rev Oncol Hematol. 2020 Mar 20;150:102944.
  _x000D_
  • Oberbauer R, Bestard O, Furian L, Maggiore U, Pascual J, Rostaing L, Budde K. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplant Rev (Orlando). 2020 Apr;34(2):100531.
  _x000D_

  _x000D_ Related Product(s)_x000D_ _x000D_ https://moleculardepot.com/product/tacrolimus-biotin-conjugate-peg11-spacer/_x000D_ _x000D_ https://moleculardepot.com/product/tacrolimus-bsa-conjugate-p2010001/_x000D_ _x000D_ https://moleculardepot.com/product/biotinylated-tacrolimus-bsa-conjugate/

• Short Description:

  Catalog #: C2010006 (1 mg or 5 mg)_x000D_ Tacrolimus Biotin Conjugate Solution is a concentrated solution of Tacrolimus (FK506) conjugated to Biotin through a PEG linker. Dilutions of the provided conjugate can be made in DMSO. The provided conjugate can be used in the research of Tacrolimus detection methods that include ELISA, Western Blots and other research applications. Custom bulk orders of this product are available upon request._x000D_ _x000D_ Live Enquiry about this product via Text/SMS: 1-858-900-3210 (8 am - 8 pm PST)

• Weight:

  32

• Length:

  8

• Width:

  6.75

• Height :

  5.5